About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, December 26th, 2013

The QualityStocks
Daily Stock List


Moller International, Inc. (MLER)

UltimatePennyStock, Investors Online Bell, Breaking Stock Reports, and OtcWizard reported earlier on Moller International, Inc. (MLER), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Moller International, Inc. is the developer of the Skycar®, which is a vertical take-off and landing (VTOL) aircraft. The Company’s volantor, called the Skycar 400, is capable of VTOL, easy to maintain, cost effective, as well as reliable. Moller International maintains that the Skycar will be usable on the road, for short distances and at low speeds. However, they believe it will excel in the air.  It will be a Personal Air Vehicle (PAV) aircraft, combined with its vertical take-off and landing capabilities. Moller International has their corporate headquarters in Davis, California.

Moller’s Skycar 400 is a powered-lift VTOL aircraft with a projected top speed of more than 350 mph and a range of approximately 800 miles. The Skycar is under development and testing. The forecast is that it will be a 4-passenger aircraft that combines the cruise performance of an airplane with the vertical-flight capabilities of a helicopter.

The M400 Skycar is classed as a "Powered-Lift" category aircraft; it is the only civilian aircraft to carry that designation. The Company plans to carry out the Official First Flight in June of 2014 at a lakeside water park north of Sacramento, California.

The Company is additionally developing Neuera. This is a directed-thrust VTOL aircraft in the late stages of production design. The multipurpose Neuera can operate up to 10 feet above any surface. Neuera can be used like other recreational vehicles, combining the capabilities of a boat, hovercraft, ATV, snowmobile or other off-road vehicle.

The Neuera can fly to 2,000 feet, but the Company indicates that the M200G model will be limited to fly only 10 feet above the ground. Products that Moller International is developing include the Skycar 400, Neuera, and newly designed one- and two-passenger models of the Skycar Light Sport (LS) series.

Moller International, Inc. (MLER), closed Thursday's trading session at $0.11, even for the day, on 73,184 volume with 13 trades. The average volume for the last 60 days is 78,775 and the stock's 52-week low/high is $0.06/$0.75.

WebSafety, Inc. (WBSI)

PennyStocks24, Greenbackers, Wallstreetlivechat, eStocks Daily, Pumps and Dumps, and Psionic Matrix reported earlier on WebSafety, Inc. (WBSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded on July 3, 2006, WebSafety, Inc. markets and sells, through the internet, a range of software applications and services for cell phones. These applications and services enable parents or other caregivers to monitor and be notified of occurrences of predator advances, cyber bullying, and pornography received on cell phones. WebSafety is based in Newport Beach, California. The Company’s shares trade on the OTC Markets’ OTCQB.

In addition, WebSafety’s cell phone application also restricts text messaging while driving. Furthermore, it provides location information to parents through using Global Positioning System (GPS) technology. The Company intends to market the products and services by developing relationships with "trusted" sources consisting of child protection advocacy groups. These include church, school, as well as civic organizations.

The Company’s intention is to explore opportunities to enter into strategic revenue sharing partnerships with companies having synergy with WebSafety’s products. These partners may include auto insurers and cell phone manufacturers.

WebSafety's advanced database technology can search more than 22,000 words, terms, and phrases that mean danger. WebSafety's technology is the only mobile parental control that contains the world's largest word recognition library of its type. The alerts instantly notify instances of sexting, texting while driving, cyber- bullying, pornography, or predatory conduct.

WebSafety’s mobile software application supports devices using the Android wireless operating system. It operates on all four of the major wireless carriers in the United States and the three major wireless carriers in Canada.

WebSafety announced in July 2103 that the Company retained the law firm of Knobbe Martens Olson & Bear, LLP to file additional patents to protect WebSafety’s proprietary technology. WebSafety intends to protect their technology in the U.S. and in other nations. Knobbe Martens Olson & Bear is one of the U.S.’s largest Intellectual Property (IP) law firms.

At present, WebSafety is revising and updating their software applications. They intend to re-launch it shortly.

WebSafety, Inc. (WBSI), closed Thursday's trading session at $0.001, up 25.00%, on 13,079,499 volume with 18 trades. The average volume for the last 60 days is 2,280,379 and the stock's 52-week low/high is $0.0005/$0.004.

TechPrecision Corp. (TPCS)

StreetInsider, FeedBlitz, and SmallCapVoice reported earlier on TechPrecision Corp. (TPCS), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., via their wholly owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., manufactures large-scale, metal fabricated and machined precision components and equipment worldwide. Their goal is to be an end-to-end global service provider to their customers through furnishing customized and integrated turn-key solutions for completed products requiring custom fabrication and machining, assembly, inspection and testing. The Company’s products are used in the energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others. TechPrecision is based in Center Valley, Pennsylvania.

The design of TechPrecision’s Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the rising worldwide demand for an experienced, knowledgeable machining and distribution center in Asia, offering large-scale component fabrication solutions for the region's solar and wind power challenges. CMC employs one of the largest forges in the industry. CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance.
The Company’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Cleantech, energy, medical, aerospace, and defense sectors. Ranor’s capabilities cover Production Control Engineering; Processing; Fabrication; Machining; Assembly & Finishing; NDE & Inspection, and Quality Assurance.

This week, TechPrecision congratulated Mevion Medical Systems on the milestone event of delivering the world's first MEVION S250 Proton Therapy System for treatment at the S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital in St. Louis, Missouri. The MEVION S250 is a unique proton therapy device. The design of it is to deliver highly precise doses of radiation while limiting unnecessary radiation to healthy tissue.  A patient with a rare type of cancer called chondrosarcoma at the base of the skull has become the first person in the world to receive proton therapy using the system.

Since 2006, TechPrecision has partnered with Mevion Systems helping to develop for the innovative, low cost and smaller proton beam radiotherapy solution for treating tumors. TechPrecision announced a five-year agreement in January 2013 with Mevion to exclusively produce precision components for their proton beam radiotherapy system.

TechPrecision Corp. (TPCS), closed Thursday's trading session at $1.23, up 14.95%, on 1,331,423 volume with 602 trades. The average volume for the last 60 days is 165,188 and the stock's 52-week low/high is $0.274/$1.42.

OurPet's Company (OPCO)

Zacks and FeedBlitz reported earlier on OurPet's Company (OPCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 1995, OurPet's Company designs, produces, and markets an extensive line of unique, high-quality accessory and consumable pet products in the United States and abroad. OurPet's sells their products to mass retailers, pet superstores and catalogues, regional pet chains, Internet, clubs, military exchange chains, grocery chains, pet food manufacturers, and pet distributors. OurPet's develops and markets products for improving the health, safety, comfort, and enjoyment of pets. The Company’s shares trade on the OTC Markets’ OTCQB. OurPet's Company is based in Fairport Harbor, Ohio.

The Company markets various pet products, including dog, cat, and bird feeders; dog and cat toys; cat and dog waste management products; catnip products; and natural and nutritional pet supplements and topical products. OurPet’s started with the development of the elevated Big Dog Feeder. This product has brought the importance of ergonomically correct eating positions to the public. The Company also has their family of Healthy Pet Diners™ and Store-N-Feed™ Diners.

Products sold by the Company have increased from the initial "Big Dog Feeder" to approximately 1,000 products for dogs, cats, and domestic and wild birds. Products are marketed under the OurPet's, Right Height, Eat, Smarter Toys, Flappy, Pet Zone, SmartScoop, Ecopure Naturals, Play-N-Squeak, Durapet, Clipnosis, and Go! Cat!Go! and Cosmic Pet labels to customers, nationally and internationally.

In late October, OurPet's Company reported that net revenue increased 34 percent to $5,737,568 and net income increased to $339,261 for the three months ended September 30, 2013, versus a net loss of $130,097 for the third quarter of 2012.  Net revenue and net income were both third quarter records. 

Gross profit margin increased more than 6 percentage points to 32.2 percent of net sales versus the same period in 2012.  Diluted earnings per share were $0.02 for the 2013 third quarter in comparison to a loss of $0.01 per share for the same period in 2012.

OurPet's Company (OPCO), closed Thursday's trading session at $0.89, up 3.49%, on 100 volume with 1 trade. The average volume for the last 60 days is 17,643 and the stock's 52-week low/high is $0.35/$2.49.

Tauriga Sciences, Inc. (TAUG)

PennyStocks24, smartOTC, and MajorPennyStocks reported recently on Tauriga Sciences, Inc. (TAUG), OTCMagic, Winston Small Cap, Penny Stock Bets did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A diversified company, Tauriga Sciences, Inc. is focusing on generating profitable revenues via license agreements and the development of a proprietary technology platform in the nano-robotics space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Tauriga Sciences’ shares trade on the OTC Markets’ OTCQB.

Tauriga has been working industriously to establish a worldwide presence via partnerships and global exclusive licenses, because their proprietary BactoBot technology can potentially address many global water related issues.

On November 25, 2013, Tauriga Sciences signed a definitive agreement to acquire Pilus Energy, LLC of Cincinnati, Ohio. Pilus Energy is a developer of alternative cleantech energy platforms employing proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Pilus Energy will become a wholly-owned subsidiary of Tauriga Sciences upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's Board of Directors.

Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also gain added revenues from carbon and renewable energy credits (REC).

This week, Tauriga Sciences announced the Company’s strong commitment to the completion of their proposed acquisition with synthetic biology pioneer Pilus Energy. Since November 25, 2013, when Tauriga announced the definitive agreement to acquire Pilus Energy, the Company has experienced extreme volatility and downward pressure on their stock price. While the recent share price volatility has been of concern to Tauriga, they still have five months to complete the requisite financing. In addition, Tauriga is encouraged by the interest level from the institutional investors. Tauriga is hopeful that at least a portion of the financing will be non-dilutive, and Company management is working hard towards that end.

Tauriga Sciences, Inc. (TAUG), closed Thursday's trading session at $0.006, up 9.09%, on 6,086,070 volume with 55 trades. The average volume for the last 60 days is 1,551,251 and the stock's 52-week low/high is $0.0035/$0.11.

Eyes on the Go, Inc. (AXCG)

PennyStocks24, Pumps and Dumps, The Stock Wrangler, Penny Champions, Penny Dreamers, MarketWireStocks, marketwirepress, fusionspicks, and Center Stage Stocks reported recently on Eyes on the Go, Inc. (AXCG), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in New York City, Eyes on the Go, Inc. is a virtual broadcasting business supplying live and recorded content from top New York City nightlife performance venues. Eyes on the Go, by way of their Gander.tv, streams this live and recorded video from nightlife venues and events. This provides entertainment, exposure, and revenue opportunities. These all make use of digital marketing and social media support. Eyes on the Go lists on the OTC Markets’ OTCQB.

In January 2012, Eyes on the Go introduced their Gander.tv service. Gander.tv works together with clients to promote awareness, interest, and attendance at venues, shows, and events. The Company builds incremental revenue via pay-per-view, advertising, as well as sponsorships. Gander.tv's mission is to provide unique, authentic content. The Gander.tv service provides online streaming video and audio images from bars, restaurants, performance spaces, and clubs to consumers through the "Gander.tv” website.

The Company has developed a proprietary software program that runs on computer platforms at customers' facilities, which streams video images and sound from multiple cameras and microphones or soundboards and makes them available to consumers on the Gander.tv website.  Eyes on the Go’s expectation is that in the future the Company will generate additional revenue through promotional programs and venue placement fees, and with select consumer product company sponsorships.

Eyes on the Go produces shorter, digestible clips of 1-5 minutes, in addition to broadcasting live content. These clips feature songs and performance segments that can link back to the original video content as it has been recorded or broadcasted live. This gives the Company the ability to repurpose their content through third party websites.

In early December, Eyes on the Go announced the addition of S.O.B.'s into their network. S.O.B.'s is a world renowned music venue featuring leading Latin and Urban artists. S.O.B.’s will add considerable content to the Eyes on the Go network, www.GANDER.tv. S.O.B.'s joins GANDER just as the Company reports that Internet traffic rose again in October to 628,000 visitor page views. This represents a 740 percent increase over September's traffic.

Eyes on the Go, Inc. (AXCG), closed Thursday's trading session at $0.0009, down 25.00%, on 33,127,095 volume with 86 trades. The average volume for the last 60 days is 24,896,085 and the stock's 52-week low/high is $0.0004/$0.0026.

Provectus Pharmaceuticals, Inc. (PVCT)

Plrinvest, Streetwise Reports, SmarTrend Newsletters, and PennyStocks24 reported on Provectus Pharmaceuticals, Inc. (PVCT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Provectus Pharmaceuticals, Inc. is a development-stage oncology and dermatology biopharmaceutical company. Their novel oncology drug is PV-10 (an injectable formulation of Rose Bengal); their dermatological drug is PH-10.  The Company’s oncology focus is on melanoma, breast cancer, and cancers of the liver. Provectus Pharmaceuticals has their headquarters in Knoxville, Tennessee.

Last week, Provectus announced that shareholders in a special meeting voted to change the Company's name to Provectus Biopharmaceuticals, Inc. and reincorporate in Delaware effective punctually upon regulatory filings in Delaware and Nevada. Provectus’ common stock will continue to trade under the symbol "PVCT" on the Over-the-Counter exchange.

The design of the Company’s PV-10 drug (a 10 percent solution of Rose Bengal) is to selectively target and destroy cancer cells without harming surrounding healthy tissue. This reduces substantially the potential for systemic side effects. Provectus has received orphan drug designations from the Food and Drug Administration (FDA) for their melanoma and hepatocellular carcinoma indications.

Their dermatological drug PH-10 targets abnormal or diseased cells. The current focus is on psoriasis and atopic dermatitis. Provectus recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.

Provectus has also developed innovative biotechnologies to augment vaccine production and detect viruses. This includes a pioneering “virus hunter” method. In addition, the Company is working on spinning out the subsidiary that contains their novel Over-The-Counter (OTC) skin care products. Provectus also looks to license patented technologies for therapeutic and cosmetic medical devices.

Provectus announced in October 2013 that they received U.S. Patent No. 8,557,298 from the United States Patent and Trademark Office (USPTO). This is a continuation-in-part of U.S. Patent No. 7,648,695. Both patents provide coverage for new chemotherapeutical medicaments and medical uses for the treatment of cancer.

Moreover, last week, Provectus announced that they held a Type C meeting with the FDA’s Division of Oncology Products 2 on December 16, 2013. The meeting’s purpose was to ascertain which of the available paths that Provectus’ novel oncology drug PV-10 will take in pursuit of FDA approval and commercialization. Under FDA rules, the agency should issue official minutes to Provectus within 30 days after such a meeting- therefore by January 15, 2014 in this particular case. The minutes will clarify the available regulatory paths and, consequently, allow Provectus to better estimate a time-line to commercialization of PV-10.

Provectus Pharmaceuticals, Inc. (PVCT), closed Thursday's trading session at $2.498, up 21.26%, on 3,266,244 volume with 1,813 trades. The average volume for the last 60 days is 836,694 and the stock's 52-week low/high is $0.53/$2.20.

Capricor Therapeutics, Inc. (CAPR)

We are reporting on Capricor Therapeutics, Inc. (CAPR) today, here at the QualityStocks Daily Newsletter.

Capricor Therapeutics, Inc. is a diversified heart failure biotechnology company. They focus on the development of novel therapeutics to prevent and treat heart disease. Last Friday, the Company announced that, effective December 20, 2013, their common stock started trading on the OTC Markets under the new symbol “CAPR.” The previous trading symbol was “NLTXD.” The ticker symbol change follows the recently completed merger between Capricor, Inc. and Nile Therapeutics, Inc. Capricor Therapeutics is based in Los Angeles, California.

The Company established through the November 2013 merger between Capricor, a privately held company whose mission is to improve the treatment of heart disease via commercializing cardiac stem cell therapies for patients, and Nile Therapeutics, a clinical-stage biopharmaceutical company developing innovative products for the treatment of cardiovascular diseases.

Capricor Therapeutics has two leading product candidates: CAP-1002 and Cenderitide. CAP-1002 is a proprietary allogeneic adult stem cell therapy for the treatment of heart disease. CAP-1002 is presently not an approved product; it is strictly for investigational purposes. The product is derived from donor heart tissue. The cells are expanded in the laboratory using a specialized process and subsequently introduced directly into a patient’s heart by way of infusion into a coronary artery using standard cardiac catheterization techniques.

The Company’s Cenderitide, a novel chimeric natriuretic peptide, is a first-in-class dual guanylyl cyclase receptor activator. Cenderitide is presently not an approved product and is also strictly for investigational purposes. Chronic dual receptor activation using a continuous subcutaneous infusion of Cenderitide is undergoing study to test whether its combination of tissue protective, renal protective, and cardiac unloading effects will help stabilize the patient’s heart and kidney function, preventing the worsening of heart failure symptoms and re-admissions to the hospital.

Cenderitide is under clinical development to treat heart failure patients during the post-acute heart failure (P-AHF) period. This is the 90-day period immediately after discharge from a hospitalization for acute decompensated heart failure.

Last week, Capricor Therapeutics announced that they received notification from the National Heart Lung and Blood Institute (NHLBI) Gene and Cell Therapy (GST) Data Safety Monitoring Board (DSMB) that the 14-patient Phase I portion of the Company’s ALLSTAR Phase I/II clinical trial has met its safety endpoints and that Capricor Therapeutics is now cleared to commence the Phase II portion of the ALLSTAR clinical trial. The Company’s ALLSTAR Phase I/II clinical trial is evaluating their CAP-1002 allogeneic cardiac-derived cell (CDC) product candidate in reducing infarct (scar) size in patients who have suffered a heart attack.

Capricor Therapeutics, Inc. (CAPR), closed Thursday's trading session at $2.72, down 10.82%, on 4,456 volume with 16 trades. The average volume for the last 60 days is 278 and the stock's 52-week low/high is $1.05/$10.00.


The QualityStocks
Company Corner


Raptor Resources Holdings Inc. (RRHI)

The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, Raptor Resources Holdings Inc. closed trading at $0.03, up 10.70%, on 115,859 volume with 5 trades. The stock’s average daily volume over the past 60 days is 88,255, and its 52-week low/high is $0.0018/$0.0395.

Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.

Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.

TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.

RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer

Raptor Resources Holdings Inc. Company Blog

Raptor Resources Holdings Inc. News:

Mabwe Minerals Receives 10,000 Ton Purchase Order

Mabwe Minerals Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification

Mabwe Minerals Commences Mining Operations at Dodge Mine

Sparta Commercial Services, Inc. (SRCO)

The QualityStocks Daily Newsletter would like to spotlight Sparta Commercial Services, Inc. (SRCO). Today, Sparta Commercial Services, Inc. closed trading at $0.7499, up 7.13%, on 32,000 volume with 12 trades. The stock’s average daily volume over the past 60 days is 19,102, and its 52-week low/high is $0.26/$0.75.

Sparta Commercial Services, Inc. (SRCO) is a New York-based technology company whose subsidiary, Specialty Reports, Inc. offers a wide range of on-line tools and products including mobile applications and information technology products.

SpecialtyMobileApps.com develops and services customized mobile applications for powersports, automobile, recreation vehicle. marine and agriculture dealers and provides dealers with access to a portal they may utilize on their own schedule to manage their application, make changes as needed and send push notifications to their customers (app users) to create a fully branded experience. The mobile application is generated, packaged, and made available on-line to the dealer's customers through the Apple App Store and the Google Play Store.

iMobileApp.com, while similar to the SMA platform, is designed for multi-industry use with both semi- and fully-customized applications available. Typical markets for the iMobileApp platform are: restaurants, hotels, medical & dental practices, real estate agencies, and attorneys.

The company also serves as a one-stop online source for various types of vehicle title history reports, including motorcycles, recreation vehicles, automobiles and light trucks, and commercial (heavy duty) trucks. Its online history report products include Cyclechex.com, a motorcycle title history report provider; RVchecks.com, a RV title history report provider; and CarVinReport.com, an automobile and light truck title history report provider, and TruckChex.com, a commercial (heavy duty) truck title history report provider.

In addition to consumers – both buyers and sellers – dealerships, insurance companies, credit unions and others have benefited from the information provided on these title history reports. The Specialty Reports, Inc. vehicle history reports are featured online at NADAGuides.com and KBB.com, the two most prominent online sources for pre-owned vehicle values and other important information for both buyers and sellers.

The company’s Municipal Leasing Program for local and/or state agencies throughout the country provides an economical way to finance essential equipment, from police motorcycles and cruisers to EMS equipment and busses, to virtually any type of equipment required. The lease purchase financing program receives considerable praise for its understanding of government acquisition procedures and its work with a wide range of vendors.

Sparta Commercial Services is an innovative and diversified company that has proven its ability to identify the needs and interests of its targeted markets, as well as develop products and services specifically designed to meet those needs and interests now and well into the future. With a full suite of offerings that solve the challenges of the powersports, recreation, and auto industries, the company is well positioned to achieve strong growth rates. Disclaimer

Sparta Commercial Services, Inc. Company Blog

Sparta Commercial Services, Inc. News:

Raleigh, NC Returns to Sparta Commercial's Municipal Lease Program for Replacement of Police Motorcycle Fleet

Specialty Reports Partners With Leading Web-Based Customer Loyalty Company for Powersports Industry

Clayton, NC Again Turns to Sparta Commercial's Municipal Lease Program

OBJ Enterprises, Inc. (OBJE)

The QualityStocks Daily Newsletter would like to spotlight OBJ Enterprises, Inc. (OBJE). Today, OBJ Enterprises, Inc. closed trading at $0.24, up 4.35%, on 107,742 volume with 35 trades. The stock’s average daily volume over the past 60 days is 7,782, and its 52-week low/high is $0.22/$0.245.

OBJ Enterprises, Inc. (OBJE) utilizes a powerful joint-venture partnership model to work alongside industry experts and universities to develop educational and popular gaming applications for the digital gaming market, the fastest-growing segment of the global IT industry. The company’s operating subsidiary, Obscene Interactive, is focused on developing innovative social gaming solutions to capitalize on the burgeoning mobile app marketplace, as well as the latest advances in media distribution platforms and advertising placement within apps.

The global gaming industry is predicted to top $66 billion in 2014. As global demand for engaging new gaming content grows with advancements in technology, OBJ Enterprises is pursuing acquisitions of emerging game development companies with portfolios of progressive technology assets such as cloud computing, discrete product placement, and micro-transactions to capitalize on the explosion in console, smartphone, and tablet usage across the globe.

Leveraging innovative and proactive partners who share the company’s vision to create next-generation digital games, OBJ Enterprises has demonstrated its invaluable ability to identify both current gaming trends and keep pace with the industry’s constant evolution. The company is constantly working on new ways to capitalize on emerging gaming trends such as biometric applications - using electronic measurement of unique human characteristics such as fingerprints and irises –for medically themed games, social games, horror games, and more.

Spearheading these growth initiatives is OBJ Enterprises CEO Paul Watson, who has domestic and international experience in fundraising for startups, growth capital, business development, and venture finance. Under his leadership and backed by a team of highly experienced management, OBJ Enterprises plans to advance its gaming portfolio to include applications in health, safety, educational, corporate, and software training. Disclaimer

OBJ Enterprises, Inc. Company Blog

OBJ Enterprises, Inc. News:

OBJE Closes in on Game Licensing Agreement

OBJE's Revenues Set to Grow With New Game

OBJE Poised for Explosion in Holiday App Downloads

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.1047, up 15.05%, on 99,553 volume with 26 trades. The stock’s average daily volume over the past 60 days is 322,124, and its 52-week low/high is $0.041/$0.14.

CD International Enterprises, Inc. (CDII) is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas, in addition to providing business and financial consulting services. Headquartered in Deerfield Beach, Florida, with corporate offices in Shanghai, CD International Enterprises’ unique infrastructure provides a platform to expand business opportunities globally.

Through its wholly owned subsidiary, International Magnesium Group, CD International Enterprises owns and operates one of the leading producers of magnesium in the world. International Magnesium Group sources its magnesium from six production facilities in the People's Republic of China, with a combined annual production and distribution capacity of approximately 80,000 metric tons of magnesium ingots and 10,000 metric tons of magnesium powder.

CD International Enterprises also sources, aggregates, and distributes iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China via wholly owned subsidiary CDII Minerals. The scope of CDII Minerals’ services include: purchasing, financing, logistics, quality control, in addition to conducting comprehensive legal, financial, and technical due diligence on suppliers.

The company’s management team possesses the necessary leadership expertise and a solid working knowledge of the unique characteristics of business operations in the U.S., China, Mexico, and South America. Employing a global growth strategy, CD International Enterprises has the unique ability to identify emerging market opportunities and provide comprehensive solutions or services relevant to conducting cross border business. Disclaimer

CD International Enterprises, Inc. Company Blog

CD International Enterprises, Inc. News:

CD International Subsidiary Completes Supply Agreement with Peruvian Mining Company to Distribute Iron Ore

CD International Enterprises and Manali Engineering-India Complete Magnesium Distribution Agreement

QualityStocks Features CD International Enterprises Vice President in Exclusive Interview

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.45, up 12.50, on 3,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 5,374, and its 52-week low/high is $0.25/$0.90.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Provides Update on $36 Million Strategic Financing Agreement

VistaGen Therapeutics Presents CardioSafe 3D and LiverSafe 3D Developments at International Society of Stem Cell Research's 11th Annual Meeting

VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue

Intelimax Media, Inc. (IXMD)

The QualityStocks Daily Newsletter would like to spotlight Intelimax Media, Inc. (IXMD). Today, Intelimax Media, Inc. closed trading at $0.02, up 5.26%, on 17,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 71,747, and its 52-week low/high is $0.0032/$0.39.

Intelimax Media, Inc. (IXMD) is a digital entertainment company specializing in fantasy sports, social gaming, entertainment, and software solutions. Primarily focused on the daily fantasy sports and social gaming sectors, the company is applying its advanced technologies to fully capitalize on the convergence of key trends in the ever-expanding social gaming space.

The company’s team of experts has identified key opportunities in the rapidly emerging daily fantasy sports and social media sectors. Leveraging its proprietary DraftTeam.com platform, the company is generating multiple revenue streams. Innovative plans for international expansion are underway to maximize exposure and traffic through various online and mobile channels.

It's estimated by the Fantasy Sports Trade Association that over 40 million people play some form of a fantasy sport each year in North America. Participation has grown over 30 percent annually the past four years with 19 percent of all males in the U.S. playing fantasy sports. Fantasy sports are estimated to have a $4–$5 billion annual economic impact across the sports industry.

Intelimax Media offers exciting and entertaining online brands that attract a loyal audience and in turn facilitate lucrative revenues from management fees, product placement, and software sales. Backed by personnel with a proven track record in the finance, growth and development of successful companies, the company is poised for rapid growth in the Internet and entertainment sectors.

Intelimax Media also trades on the Canadian market under the symbol (IMD). Disclaimer

Intelimax Media, Inc. Company Blog

Intelimax Media, Inc. News:

Intelimax Announces Adoption of Advance Notice Policy

Intelimax Updates Membership Growth Disclosure

Intelimax launches 2013/14 NHL Hockey on DraftTeam.com

Big Tree Group, Inc. (BIGG)

The QualityStocks Daily Newsletter would like to spotlight Big Tree Group, Inc. (BIGG). Today, Big Tree Group, Inc. closed trading at $0.23, up 2.22%, on 561,270 volume with 18 trades. The stock’s average daily volume over the past 60 days is 63,221, and its 52-week low/high is $0.055/$2.99.

Big Tree Group, Inc. (BIGG) is an authorized sales agent for thousands of toy manufacturers in China and provides multiple procurement services for international toy distributors and wholesalers. The company is headquartered in Shantou City of Guangdong province, a city known as the toy capital of the world. It’s here that Big Tree operates a 21,000-square-foot-showroom to display its products to thousands of international toy purchasers. The company has an on-site testing laboratory where all toys undergo rigorous testing to ensure both quality and function before reaching the showroom floor.

Big Tree Group serves as a “one-stop-shop” for the international sourcing and distribution of toys and other related products. Big Tree Group currently represents more than 8,000 toy manufacturers offering more than 300,000 varieties of toy products such as remote control toys, digital toys, sports toys, play sets, educational toys, dolls and infant toys. Big Tree conducts operations through both of their subsidiaries, Big Tree Brunei and Big Tree Shantou.

The company has developed and patented a proprietary construction toy, the Magic Puzzle (3D). The Big Tree Magic Puzzle has been well received but is currently promoted and distributed in only the Chinese domestic market. Global marketing and distribution of the Magic Puzzle is under evaluation and could create significant channels sales.

China is the world’s leading toy manufacturer and exporter, producing and distributing two-thirds of the multi-billion dollar toy industry’s global demand. The nation’s manufacturing is highly regional, with 70 percent of toy sales in China generated in the Guangdong province. Strategically located in this province, Big Tree has cultivated an extensive customer base in Asia and Europe and is strategically planning global expansion and distribution, especially in the Americas.

Big Tree’s operations are spearheaded by long-time China toy industry veteran CEO Wei Lin, who founded the toy export and import company Shantou Dashu Toy Corp. Ltd. He is supported by an seasoned and experienced management team proficient in operations management, marketing, sales, team management, education and accounting. Big Tree’s management team has established an aggressive growth strategy to expand sales and global product distribution by utilizing their expansive multi-lingual sales team to leverage industry contacts, identify strategic mergers and acquisitions, and maximize trade and industry opportunities. Disclaimer

Big Tree Group, Inc. Company Blog

Big Tree Group, Inc. News:

Big Tree Group to Open Toy Sales and Distribution Center in Thailand to Expand Its Presence in the Southeast Asia Market

Big Tree Group Provides Financial Forecast for 2013 Year End Financial Results and Outlook for 2014

Big Tree Group, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2013

StreamTrack, Inc. (STTK)

The QualityStocks Daily Newsletter would like to spotlight StreamTrack, Inc. (STTK). Today, StreamTrack, Inc. closed trading at $0.0052, up 1.96%, on 426 volume with 1 trade. The stock’s average daily volume over the past 60 days is 50,285, and its 52-week low/high is $0.0011/$2.125.

StreamTrack, Inc. (STTK), a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company's platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.

StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.

WatchThis™, StreamTrack's patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.

StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company's growth potential and profitability. Disclaimer

StreamTrack, Inc. Company Blog

StreamTrack, Inc. News:

StreamTrack Acquires Robot Fruit Mobile Application Software

StreamTrack Announces Cancellation of Potential $2.5 Million Royalty Liability

StreamTrack's RadioLoyalty Signs TargetSpot


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Real Pennies


Pumps and Dumps


SmallCap Network

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251